Literature DB >> 22675113

Skin spread from an intracranial glioblastoma: case report and review of the literature.

Ignacio Jusué Torres1, Pilar Jerez Fernández, Jose Ortega Zufiría, Jose María Rodríguez Barbero.   

Abstract

Extracranial metastases secondary to intracranial neoplasm are extremely rare. The incidence of extraneural metastases of brain tumours is estimated to be less than 0.4%. The authors report a case of postoperative intracranial glioblastoma spreading to the skin in an adult patient. In this case, the radiological images and surgical findings suggest that the potential dissemination mechanism is as a result of infiltration through the surgical wound site. The primary tumour-upon coming into contact with the dura and the skin-mimicked the characteristics of both tissues. This case supports the theory of risk of spread through the durotomy site, although this phenomenon is extremely rare. Both the specific pathogenic mechanisms as well as the ideal and effective management have not been established yet and require further investigation.

Entities:  

Mesh:

Year:  2011        PMID: 22675113      PMCID: PMC3207803          DOI: 10.1136/bcr.09.2011.4858

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  16 in total

1.  Autotransplantation of anaplastic astrocytoma into the subcutaneous tissue of man.

Authors:  A F BATTISTA; W BLOOM; M LOFFMAN; I FEIGIN
Journal:  Neurology       Date:  1961-11       Impact factor: 9.910

2.  Cutaneous metastasis from glioblastoma.

Authors:  N Jain; M Mirakhur; P Flynn; K A Choudhari
Journal:  Br J Neurosurg       Date:  2005-02       Impact factor: 1.596

3.  Skin metastases of glioblastoma in the absence of intracranial progression are associated with a shift towards a mesenchymal immunophenotype: report of two cases.

Authors:  Rebecca Senetta; Elisa Trevisan; Roberta Rudà; Franco Benech; Riccardo Soffietti; Paola Cassoni
Journal:  Acta Neuropathol       Date:  2009-05-06       Impact factor: 17.088

Review 4.  Metastasizing glioblastoma multiforme diagnosed during life of patients: case report and review of literature.

Authors:  S Shuangshoti; C Taecholarn; V Kasantikul
Journal:  J Med Assoc Thai       Date:  1988-06

5.  Glioblastoma multiforme with extraneural metastases in the absence of previous surgery.

Authors:  S Hulbanni; P A Goodman
Journal:  Cancer       Date:  1976-03       Impact factor: 6.860

6.  [Extracranial metastasis of glioblastoma multiforme].

Authors:  Angelina V Santos; Paulo F Saraiva; Bruno Santiago
Journal:  Acta Med Port       Date:  2003 May-Jun

Review 7.  Metastasis to and from the central nervous system--the 'relatively protected site'.

Authors:  A Subramanian; A Harris; K Piggott; C Shieff; R Bradford
Journal:  Lancet Oncol       Date:  2002-08       Impact factor: 41.316

8.  Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients.

Authors:  D P Lookingbill; N Spangler; K F Helm
Journal:  J Am Acad Dermatol       Date:  1993-08       Impact factor: 11.527

9.  Glioblastoma multiforme in skin: a report of 2 cases and review of the literature.

Authors:  Mark Mentrikoski; Mahlon D Johnson; David N Korones; Glynis A Scott
Journal:  Am J Dermatopathol       Date:  2008-08       Impact factor: 1.533

10.  Fine needle aspiration diagnosis of extracranial glioblastoma multiforme: Case report and review of the literature.

Authors:  Stacey Schultz; Gregory S Pinsky; Nancy C Wu; Marc C Chamberlain; A Sonali Rodrigo; Sue E Martin
Journal:  Cytojournal       Date:  2005-11-14       Impact factor: 2.091

View more
  2 in total

1.  A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center.

Authors:  Evan K Noch; Sameer F Sait; Shama Farooq; Tanya M Trippett; Alexandra M Miller
Journal:  Neurooncol Pract       Date:  2021-02-03

Review 2.  Intracranial dissemination of glioblastoma multiforme: a case report and literature review.

Authors:  Keke Zhang; Yihang Yang; Jianfeng Zhuang; Gengyin Guo; Xin Chao; Zhen Zhang
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.